Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Leukocare AG logo — Experts in Sterile Drug Product Development Services

Leukocare AG

Experts in Sterile Drug Product Development Services

Founded 2003 Germany Planegg, Germany 46 employees Debt Financing Total: $17.50M AI, Biotechnology +2

General Information

Company Name Leukocare AG
Founded Year 2003
Location Germany Planegg, Germany +2
Employees 46
Industries AI, Biotechnology, Health Care +1
Funding Stage Debt Financing
Social

Get notified when Leukocare AG moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Leukocare AG

Leukocare AG is a biotechnology company, based in Germany and founded in 2003. The company is an innovator in drug product development for biologics, focusing on tailored services to enhance the stability and formulation of drug products, thus extending shelf life and streamlining logistics, thereby mitigating risks in drug development programs. What sets Leukocare apart from others is its utilization of bioinformatics and biostatistics-based approaches in the Design of Experiment (DoE) to explore a wider design space for identifying the optimal combination of excipients. This unique approach synergizes in-silico methods with wet lab experiments, ultimately reducing the number of experiments required and the need for high throughput. Furthermore, this also results in reduced usage of drug substance and accelerated development time. The company's database of over 100+ regulatory approved excipients contributes to reducing obstacles in later clinical stages. In addition to formulation development, Leukocare offers analytical and bioinformatics services for ongoing drug discovery and development projects, demonstrating strong expertise in particle characterization, stability analysis, and molecular integrity assessment, among others. The latest investment in Leukocare AG was a $2.50M Venture Round investment on 23 June 2021, led by Petrichor Healthcare. This investment is anticipated to further propel the company's innovative approach in providing specialized drug product development services for biologics.

Taxonomy: biopharmaceutical formulation development, drug product development, bioinformatics, biostatistics, formulation development, analytical services, in-silico methods, excipients, regulatory approved, particle characterization, molecular integrity analysis, stability prediction, Lyo optimization, viral vectors

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1 •••• •••• 23 Jun 2021
Debt Financing •••••• 1 •••• •••• 23 Jun 2021
Venture Round •••••• 1 •••• •••• 22 Jul 2015

Leukocare AG Alternatives & Competitors

Leukocare AG vs
Pyramid Labs
Pyramid Labs United States

A Reliable CDMO Partner for Injectable drug products. From Development to Commercial Manufacturing.

Private Equity
70 employees
Manufacturing
Compare Leukocare AG vs Pyramid Labs
Leukocare AG vs
Drug Development & Delivery
Drug Development & Delivery United States

The Science & Business of Pharmaceutical and Biological Drug Development

8 employees
Health Care, Pharmaceutical
Leukocare AG vs
RAPTAKOS BRETT & CO.
RAPTAKOS BRETT & CO.

RBCRS provides focused services for formulation development, analytical method development, Neutrace...

742 employees
Health Care
Also compare with: Leukocare AG vs Bionter Bionter Leukocare AG vs Nanopharm Ltd, an Aptar Pharma Company Nanopharm Ltd, an Aptar Pharma Company

FAQ About Leukocare AG

Experts in Sterile Drug Product Development Services
Leukocare AG was founded in 2003.
Leukocare AG is headquartered in Planegg, Germany.
Leukocare AG operates in the following industries: AI, Biotechnology, Health Care, Medical Devices.
Leukocare AG has approximately 46 employees.
Leukocare AG has completed 3 funding rounds, raising a total of $17.50M. The latest funding stage is Debt Financing.
Top alternatives and competitors to Leukocare AG include Pyramid Labs, Drug Development & Delivery, RAPTAKOS BRETT & CO., Bionter, Nanopharm Ltd, an Aptar Pharma Company. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Leukocare AG and Pyramid Labs are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Leukocare AG and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy